Cite
HARVARD Citation
Rademakers, S. et al. (n.d.). Prognostic value of the proliferation marker Ki‐67 in laryngeal carcinoma: Results of the Accelerated Radiotherapy with Carbogen Breathing and Nicotinamide phase III randomized trial. Head & neck. 37 (2), pp. 171-176. [Online].